Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock
January 21, 2010 18:34 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - January 21, 2010) - The Board of Directors of Marshall Edwards,
Inc. today advised that analysis of tumor response data from the OVATURE
trial will be performed in the...
Marshall Edwards, Inc. to Present at the 27th Annual JPMorgan Healthcare Conference
January 14, 2009 08:59 ET
|
Marshall Edwards, Inc.
WASHINGTON, DC--(Marketwire - January 14, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL) will
present at the 27th Annual JPMorgan Healthcare Conference in San Francisco
on Thursday January 15, 2008 at...
Marshall Edwards, Inc. Files IND Application for Triphendiol
December 01, 2008 08:10 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - December 1, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) today
announced that it has filed an application with the United States Food and
Drug Administration for an...
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
November 13, 2008 08:10 ET
|
Novogen, Limited
NEW CANAAN, CT--(Marketwire - November 13, 2008) - The Independent Data Monitoring Committee
(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial,...
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
November 12, 2008 08:10 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - November 12, 2008) - The Independent Data Monitoring Committee
(IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor
REsponse (OVATURE) Trial,...
Novogen's Investigational Drug for Inflammatory Bowel Disease Has Positive Results Following Phase Ib Trial
December 04, 2007 08:01 ET
|
Novogen, Limited
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed
Phase Ib clinical trial of a new drug to treat inflammatory bowel disease
(IBD) indicates that treatment may...
Research Indicates Synthetic Compound NV-52 May Be Useful in Treatment of Inflammatory Bowel Disease
November 13, 2007 08:04 ET
|
Novogen, Limited
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - November 13, 2007) - An article published
in a recent edition of the peer review journal Expert Opinion, Vol. 16, No.
8, reveals the compound...
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
October 22, 2007 19:00 ET
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and BERLIN and NEW CANAAN, CT--(Marketwire - October 22, 2007) - A symposium
on platinum resistant ovarian cancer will be held at the European Society
for Gynecological Oncology in...